EKF Diagnostics (LON:EKF) Share Price Crosses Above 200 Day Moving Average – What’s Next?

Shares of EKF Diagnostics Holdings plc (LON:EKF) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 25.27 and traded as high as GBX 27.40. EKF Diagnostics shares last traded at GBX 26.45, with a volume of 100,751 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Stifel Nicolaus restated a “buy” rating and set a GBX 35 price objective on shares of EKF Diagnostics in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of GBX 35.

EKF Diagnostics Price Performance

The stock has a market cap of £113.85 million, a price-to-earnings ratio of 56.27 and a beta of 0.49. The company has a debt-to-equity ratio of 2.01, a quick ratio of 1.77 and a current ratio of 4.16. The company has a 50-day simple moving average of GBX 24.89 and a two-hundred day simple moving average of GBX 25.27.

EKF Diagnostics (LON:EKF) last released its quarterly earnings data on Tuesday, March 24th. The company reported GBX 0.47 EPS for the quarter. EKF Diagnostics had a return on equity of 3.01% and a net margin of 4.12%. As a group, equities research analysts forecast that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current year.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.